Feb 8, 2012 | Nurse.com
FDA: PPI use can increase risk of C-difficile diarrhea
The Food and Drug Administration notified the public that the use of proton pump inhibitors may be associated with an increased risk of Clostridium difficile- associated diarrhea.
H2 blockers, also called H2-receptor antagonists, are medicines that reduce the amount of acid the stomach produces by blocking one important producer of acid: histamine2.
Glenmark Pharma gets Us Fda Final Approval For Nizatidine Capsules
Glenmark Pharmaceuticals Ltd. announced today that its subsidiary Glenmark Generics had been granted final approval for its abbreviated new rrug application by the US FDA for Nizatidine Capsules.
Risks of pneumonia may be increased due to heartburn drugs
Recent study shows a startling finding that drugs commonly used to treat heartburn could actually shoot up the likelihood of having pneumonia.
Also on Topix